XML 32 R12.htm IDEA: XBRL DOCUMENT v3.25.0.1
Equity-based Compensation Plans
 12 Months Ended
Dec. 31, 2024
Share-Based Payment Arrangement [Abstract]  
Equity-based Compensation Plans Equity-based Compensation Plans
Our 2021 Equity-based Compensation Plan (the “2021 Plan”) provides for the granting of incentive stock options, non-statutory stock options, stock appreciation rights, restricted stock awards, restricted stock unit awards, performance awards, and other equity-based awards. The number of shares of our common stock reserved for issuance under the 2021 Plan will be increased on January 1 of each calendar year through January 1, 2031. As of December 31, 2024, the maximum number of shares of our common stock that may be issued under the Plans is 480,960,672 shares and 315,173,683 shares of common stock are available for future grants to employees.
Shares subject to stock awards granted under the 2021 Plan that expire or terminate without being exercised in full, or that are paid out in cash rather than in shares, do not reduce the number of shares available for issuance under the 2021 Plan. Additionally, shares become available for future grant under the 2021 Plan if they were issued under stock awards under the 2021 Plan and we repurchase them or they are forfeited.
RSUs
RSUs generally vest over 2 to 4 years from the vesting start date, subject to the recipient remaining an employee at each vesting date.
As of December 31, 2024, we had $904 million of unamortized compensation costs related to all unvested RSU awards. The unamortized compensation costs are expected to be recognized over a weighted-average period of approximately 2.6 years, net of estimated forfeitures.
The table below summarizes our RSU activity:
Outstanding RSUs
(in millions, except unit price)
Number of RSUsWeighted Average Grant-Date Fair Value
December 31, 202346 $17.25 
Granted44 19.77 
Vested(19)17.53 
Forfeited / cancelled(7)17.92 
December 31, 202464 $18.82 
The following information is provided for our RSUs:
(in millions, except unit price)
202420232022
Weighted average grant-date fair value of RSUs granted$19.77 $16.31 $17.24 
Fair value of RSUs at vesting$402 $223 $181 
Stock Options
In the past, we granted stock options to certain employees. Stock options generally expire ten years from the grant date.
The table below summarizes our stock option activity:
Outstanding Options
(in millions, except unit price)
Number
of
Options		Weighted
Average Exercise
Price		Weighted-Average
Remaining Contractual
Term (in years)		Aggregate Intrinsic Value
December 31, 202317 $7.60 4.90$152 
Forfeited / cancelled— $2.02 
Exercised(2)$2.34 
Exercised Withheld— $2.15 
December 31, 202415 $8.26 3.83$213 
Exercisable as of December 31, 202415 $8.39 3.82$206 
Expected to vest as of December 31, 2024— $1.99 4.38$6 
The following information is provided for our stock options:
(in millions, except unit price)
202420232022
Intrinsic fair value of stock options exercised$35 $57 $131 
Equity-based Compensation Expense
The following table presents the effects of equity-based compensation on the consolidated statements of operations:
(in millions)
202420232022
Cost of sales$17 $14 $16 
Operating, general and administrative416 312 246 
Total$433 $326 $262